Tyndall Capital Partners’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History

Tyndall Capital Partners’s Portfolio ONTXW Stock Details ONTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-390,624	Closed	-$14K	–	2
2019 Q4	$14K	Hold	390,624	–	–	0.6%	2
2019 Q3	$8K	Hold	390,624	–	–	0.3%	3
2019 Q2	$70K	Hold	390,624	–	–	1.42%	3
2019 Q1	$74K	Hold	390,624	–	–	1.46%	3
2018 Q4	$16K	Hold	390,624	–	–	0.45%	3
2018 Q3	$39K	Hold	390,624	–	–	0.49%	3
2018 Q2	$5K	Hold	390,624	–	–	0.07%	3
2018 Q1	$117K	Hold	390,624	–	–	3.05%	3
2017 Q4	$215K	Hold	390,624	–	–	6.19%	3
2017 Q3	$152K	Hold	390,624	–	–	1.94%	4
2017 Q2	$176K	Hold	390,624	–	–	2.08%	4
2017 Q1	$327K	Hold	390,624	–	–	9.4%	3
2016 Q4	$391K	Hold	390,624	–	–	13.7%	3
2016 Q3	$391K	Buy	+390,624	New	+$413K	21.2%	2

Tyndall Capital Partners's ONTXW Position: Q1 2020 in Review

Tyndall Capital Partners sold out of Onconova Therapeutics, Inc. Warrants (ONTXW) in Q1 2020, closing a stake of 390,624 shares — an estimated $14K sold.

Tyndall Capital Partners first reported a position in ONTXW in Q3 2016 and held it in 14 quarters. The position peaked at $391K in Q4 2016. 1 fund tracked by Wall St. Rank holds ONTXW as of Q1 2020.

Tyndall Capital Partners reported no remaining Onconova Therapeutics, Inc. Warrants position as of Q1 2020 after selling out during the quarter.
Tyndall Capital Partners sold 390,624 Onconova Therapeutics, Inc. Warrants shares in Q1 2020, an estimated $14K.
Tyndall Capital Partners first reported a position in Onconova Therapeutics, Inc. Warrants in Q3 2016 and held it in 14 quarters.
Tyndall Capital Partners's Onconova Therapeutics, Inc. Warrants position peaked at $391K in Q4 2016.
1 fund tracked by Wall St. Rank held Onconova Therapeutics, Inc. Warrants as of Q1 2020.

Based on Tyndall Capital Partners's 13F filing for Q1 2020.